{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:40:51Z","timestamp":1789663251026,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702790"],"award-info":[{"award-number":["81702790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tranon.2025.102465","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:37:14Z","timestamp":1751384234000},"page":"102465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Isolated tumor cell clusters (ITC) in lymph nodes and PD-L1 expression on tumor-associated immune cells are prognostic factors for microsatellite instable-high gastric cancers"],"prefix":"10.1016","volume":"59","author":[{"given":"Menghan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1695-3127","authenticated-orcid":false,"given":"Fengxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102465_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2025.102465_bib0002","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.tranon.2025.102465_bib0003","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102465_bib0004","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10120-024-01523-4","article-title":"Potent therapeutic strategy in gastric cancer with microsatellite instability-high and\/or deficient mismatch repair","volume":"27","author":"Ooki","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.tranon.2025.102465_bib0005","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1007\/s00018-018-2906-9","article-title":"Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches","volume":"75","author":"Ratti","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tranon.2025.102465_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bjs.10663","article-title":"Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer","volume":"105","author":"Polom","year":"2018","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.tranon.2025.102465_bib0007","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4132\/KoreanJPathol.2013.47.1.28","article-title":"Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes","volume":"47","author":"Kim","year":"2013","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.tranon.2025.102465_bib0008","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jso.21220","article-title":"Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype","volume":"99","author":"Seo","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.tranon.2025.102465_bib0009","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10120-012-0226-6","article-title":"Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach","volume":"16","author":"Arai","year":"2013","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.tranon.2025.102465_bib0010","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/cas.14301","article-title":"Solid-type poorly differentiated adenocarcinoma of the stomach: deficiency of mismatch repair and SWI\/SNF complex","volume":"111","author":"Tsuruta","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2025.102465_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/apm.12345","article-title":"Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma","volume":"123","author":"Choi","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.tranon.2025.102465_bib0012","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","article-title":"Assessment of a HER2 scoring system for gastric cancer: results from a validation study","volume":"52","author":"Hofmann","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.tranon.2025.102465_bib0013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-010-0952-2","article-title":"HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing","volume":"457","author":"R\u00fcschoff","year":"2010","journal-title":"Virchows Arch."},{"key":"10.1016\/j.tranon.2025.102465_bib0014","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","article-title":"HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Bartley","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102465_bib0015","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/modpathol.2016.55","article-title":"A protein and mRNA expression-based classification of gastric cancer","volume":"29","author":"Setia","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.tranon.2025.102465_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.712760","article-title":"The impact of mismatch repair status on prognosis of patients with gastric cancer: a multicenter analysis","volume":"11","author":"Guan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2025.102465_bib0017","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.2147\/CMAR.S274187","article-title":"Implication of microsatellite instability in Chinese cohort of human cancers","volume":"12","author":"Cui","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tranon.2025.102465_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102175","article-title":"Microsatellite instability in gastric cancer: between lights and shadows","volume":"95","author":"Puliga","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tranon.2025.102465_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000470","article-title":"Assessing molecular subtypes of gastric cancer microsatellite unstable and Epstein-Barr virus subtypes","volume":"4","author":"Martinez-Ciarpaglini","year":"2019","journal-title":"ESMO Open"},{"key":"10.1016\/j.tranon.2025.102465_bib0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1245\/s10434-015-4931-3","article-title":"Strong prognostic value of microsatellite instability in intestinal type non-cardia gastric cancer","volume":"23","author":"Marrelli","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.tranon.2025.102465_bib0021","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5009\/gnl15133","article-title":"Usefulness of immunohistochemistry for microsatellite instability screening in gastric cancer","volume":"9","author":"Bae","year":"2015","journal-title":"Gut. Liver"},{"key":"10.1016\/j.tranon.2025.102465_bib0022","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13304-017-0420-5","article-title":"Clinical significance of lymph nodes micrometastasis in conventionally node-negative advanced gastric cancer","volume":"69","author":"Blouhos","year":"2017","journal-title":"Updates Surg."},{"key":"10.1016\/j.tranon.2025.102465_bib0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10549-011-1771-0","article-title":"Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location","volume":"131","author":"Vestjens","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tranon.2025.102465_bib0024","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/bjs.5604","article-title":"Proliferative activity of micrometastases in the lymph nodes of patients with gastric cancer","volume":"94","author":"Yonemura","year":"2007","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.tranon.2025.102465_bib0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jss.2007.04.037","article-title":"Sentinel node micrometastases have high proliferative potential in gastric cancer","volume":"145","author":"Yanagita","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.tranon.2025.102465_bib0026","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2025.102465_bib0027","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10120-010-0556-1","article-title":"The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients","volume":"13","author":"Fukagawa","year":"2010","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.tranon.2025.102465_bib0028","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41416-018-0052-7","article-title":"Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study","volume":"118","author":"Liikanen","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tranon.2025.102465_bib0029","first-page":"6836","article-title":"Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer","author":"Hosch","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2025.102465_bib0030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1200\/JCO.2011.35.9539","article-title":"Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer","volume":"30","author":"Mescoli","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102465_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182692","article-title":"PD-L1 and gastric cancer prognosis: a systematic review and meta-analysis","volume":"12","author":"Gu","year":"2017","journal-title":"PLos One"},{"key":"10.1016\/j.tranon.2025.102465_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152881","article-title":"High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features","volume":"216","author":"Liu","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.tranon.2025.102465_bib0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13000-020-00979-z","article-title":"Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas","volume":"15","author":"Choi","year":"2020","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.tranon.2025.102465_bib0034","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00428-020-02956-9","article-title":"Scoring systems for PD-L1 expression and their prognostic impact in patients with resectable gastric cancer","volume":"478","author":"Pereira","year":"2021","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.tranon.2025.102465_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3892\/ol.2023.14153","article-title":"Prognostic value of PD\u2011L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer","volume":"27","author":"Zou","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2025.102465_bib0036","first-page":"102","article-title":"Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment","author":"Quan","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tranon.2025.102465_bib0037","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10120-018-00918-4","article-title":"Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer","volume":"22","author":"Hashimoto","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.tranon.2025.102465_bib0038","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/s41598-019-41177-2","article-title":"PD-L1 expression combined with microsatellite instability\/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer","volume":"9","author":"Morihiro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2025.102465_bib0039","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1200\/JCO.23.01601","article-title":"First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-year follow-up of the phase III CheckMate 649 trial","volume":"42","author":"Janjigian","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102465_bib0040","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","article-title":"Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials","volume":"7","author":"Chao","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.tranon.2025.102465_bib0041","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2025.102465_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tranon.2025.102465_bib0043","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T07:20:47Z","timestamp":1752909647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S1936523325001962"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102465","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated tumor cell clusters (ITC) in lymph nodes and PD-L1 expression on tumor-associated immune cells are prognostic factors for microsatellite instable-high gastric cancers","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102465"}}